Comments on "Abiraterone acetate plus prednisolone for metastatic patients starting hormone therapy: 5‐year follow‐up results from the STAMPEDE randomised trial (NCT00268476)". Issue 12 (5th September 2022) - Cattrini, Carlo; Messina, Carlo; Mennitto, Alessia; Di Maio, Massimo; Gennari, Alessandra; Olmos, David